
VRXA P/E Ratio
P/E Ratio as of Jun 11, 2026: 115.73
Average115.73
Median115.73
Minimum115.73
Maximum115.73
115.73
The P/E ratio for VRXA is 115.73 as of Jun 11, 2026. This represents a increase of 1,100.52% compared to its 12-month average P/E ratio of 9.64. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Veraxa Biotech Holding AG P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Veraxa Biotech Holding AG’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Veraxa Biotech Holding AG to industry peers.
Veraxa Biotech Holding AG P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Veraxa Biotech Holding AG’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Veraxa Biotech Holding AG to industry peers.
VRXA P/E Ratio Insights
See Veraxa Biotech Holding AG’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in VRXA
Order type
Buy in
Order amount
Est. shares
0 shares
VRXA P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 11, 2026 | $24.79 | 115.73 |
VRXA End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 115.73 | — |
FAQs About Veraxa Biotech Holding AG (VRXA) P/E ratio
The latest P/E ratio of VRXA is 115.73, as of Jun 11, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Veraxa Biotech Holding AG’s last 12-month average P/E ratio is 9.64, compared to its current P/E ratio of 115.73. This reflects a increase of 1,100.52%.
Veraxa Biotech Holding AG’s current P/E ratio of 115.73 is higher than its last 12-month average P/E of 9.64. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Veraxa Biotech Holding AG’s average P/E ratio over the last 3 years is 3.21. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Veraxa Biotech Holding AG’s average P/E ratio over the last 5 years is 1.93. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.